- Issuer ticker
-
APYX
- Reported as of
-
11 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
15 Jun 2026, 19:00:05 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Lawrence J. Waldman
Key filing fact
Lawrence J. Waldman filed Form 4 for Apyx Medical Corp (APYX) on 15 Jun 2026.
Key facts
- This page summarizes Lawrence J. Waldman's Form 4 filing for Apyx Medical Corp (APYX).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 15 Jun 2026, 19:00.
Change
- Previous filing in this sequence was filed on 26 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001516592
Primary reporting owner
Waldman Lawrence
- Relationship
-
Director
- Address
- C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER
- Signature
- /s/ Lawrence J. Waldman
- Signature date
- 15 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
APYX
transaction
Derivative
Stock Option (Option to Buy)
Award
- Transaction value
- Shares
- +50,000
- Change %
- Price
-
$0.000000*
- Shares after
- 50,000
- Date
- 11 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $4.65
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote